ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

30,049Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 1171

$1.51M Total Retail Price of All Prescriptions

Rank: 12 out of 1171

1,207 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 1,207 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

17% of this provider’s 1,207 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 26,904 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
HYDROCODONE-ACETAMINOPHEN 1,235 1,012 S3 1 8
LISINOPRIL 970 909 2 3
SIMVASTATIN 902 824 3 1
AMLODIPINE BESYLATE 809 762 4 2
OMEPRAZOLE 785 673 5 5
LEVOTHYROXINE SODIUM 770 675 6 4
FUROSEMIDE 744 675 7 6
POTASSIUM CHLORIDE 744 675 7 19
METOPROLOL TARTRATE 568 554 9 11
ATENOLOL 566 430 10 15
TORSEMIDE 512 492 11 150
HYDROCHLOROTHIAZIDE 484 441 12 9
METOPROLOL SUCCINATE 441 429 13 17
GLIMEPIRIDE 397 378 14 34
WARFARIN SODIUM 381 339 15 12
METFORMIN HCL 380 348 16 7
ATORVASTATIN CALCIUM 355 320 17 10
METFORMIN HCL ER 347 296 18 52
NEXIUM 329 307 19 25
GABAPENTIN 324 292 20 16
CLOPIDOGREL 300 290 21 35
DONEPEZIL HCL 298 298 22 24
ALLOPURINOL 298 253 22 31
PRAVASTATIN SODIUM 295 282 24 13
FLUTICASONE PROPIONATE 294 273 25 30
PREDNISONE 290 274 26 39
CARVEDILOL 288 267 27 20
RANITIDINE HCL 287 268 28 38
LISINOPRIL-HYDROCHLOROTHIAZIDE 274 250 29 26
CITALOPRAM HBR 248 187 30 22
DIGOXIN 247 230 31 68
GEMFIBROZIL 246 211 32 117
PANTOPRAZOLE SODIUM 240 221 33 29
TRIAMTERENE-HCTZ 233 183 34 58
PLAVIX 226 218 35 55
ISOSORBIDE MONONITRATE ER 224 193 36 44
ENALAPRIL MALEATE 193 158 37 73
SYNTHROID 192 185 38 48
TRAZODONE HCL 188 180 39 37
AZITHROMYCIN 183 155 40 43
PAROXETINE HCL 181 145 41 62
ALPRAZOLAM 178 170 42 184
LOSARTAN POTASSIUM 172 157 43 14
MELOXICAM 162 132 44 56
AMITRIPTYLINE HCL 162 130 R 44 74
TAMSULOSIN HCL 158 158 46 28
CLONIDINE HCL 157 157 47 45
LEVOFLOXACIN 153 135 48 105
NAMENDA 140 140 49 42
KLOR-CON M20 140 137 49 41
SOTALOL 138 134 51 294
TRAMADOL HCL 136 115 52 18
DILTIAZEM 24HR ER 134 120 53 112
GLIPIZIDE ER 133 102 54 86
QUETIAPINE FUMARATE 132 116 55 54
RAMIPRIL 126 118 56 85
SERTRALINE HCL 126 116 56 23
PREMARIN 125 90 R 58 237
PROAIR HFA 123 87 59 49
HYDRALAZINE HCL 121 117 60 60
SPIRONOLACTONE 120 101 61 53
TRICOR 119 96 62 140
CYCLOBENZAPRINE HCL 118 89 R 63 67
LOSARTAN-HYDROCHLOROTHIAZIDE 117 109 64 40
CIPROFLOXACIN HCL 114 101 65 61
CYMBALTA 111 100 66 64
LANSOPRAZOLE 111 97 66 150
ALENDRONATE SODIUM 108 104 68 33
CRESTOR 107 93 69 27
MECLIZINE HCL 105 86 70 115
NAPROXEN 105 88 70 95
VERAPAMIL ER 102 86 72 91
FLUOCINONIDE 102 98 72 249
QUINAPRIL HCL 102 98 72 156
DILTIAZEM 24HR CD 101 101 75 101
RISPERIDONE 101 96 75 77
ZOLPIDEM TARTRATE 99 91 77 21
PROPRANOLOL HCL 98 98 78 134
FELODIPINE ER 96 96 79 165
HUMULIN 70-30 96 91 79 183
BUMETANIDE 95 89 81 93
DIOVAN HCT 92 80 82 65
NORTRIPTYLINE HCL 92 75 82 263
DOXEPIN HCL 87 43 84 293
CLOTRIMAZOLE-BETAMETHASONE 86 84 85 174
DIOVAN 86 75 85 32
GLIPIZIDE XL 85 78 87 124
ETODOLAC 85 78 87 236
ESCITALOPRAM OXALATE 85 74 87 69
NOVOLIN 70-30 84 84 90 242
BISOPROLOL-HYDROCHLOROTHIAZIDE 80 71 91 166
CEFDINIR 76 70 92 197
AGGRENOX 76 63 92 148
PHENYTOIN SODIUM EXTENDED 75 57 94 137
DOXAZOSIN MESYLATE 75 75 94 82
ZETIA 74 74 96 63
AMIODARONE HCL 74 74 96 192
LEVETIRACETAM 74 61 96 84
VENLAFAXINE HCL ER 73 61 99 113
SULFAMETHOXAZOLE-TRIMETHOPRIM 73 68 99 109
INSULIN SYRINGE 72 47 101 71
TOPROL XL 70 66 102 324
DOXYCYCLINE HYCLATE 70 63 102 137
NIFEDIPINE ER 69 69 104 114
LIPITOR 67 63 105 92
FENOFIBRATE 66 46 106 81
LANTUS 64 53 107 46
ADVAIR DISKUS 63 53 108 51
PRADAXA 63 55 108 248
NOVOLOG MIX 70-30 62 62 110 207
IPRATROPIUM-ALBUTEROL 62 62 110 130
SPIRIVA 61 51 112 57
PROPAFENONE HCL 61 61 112 374
BENICAR 61 61 112 181
LORAZEPAM 60 60 115 335
BENAZEPRIL HCL 59 50 116 83
METHIMAZOLE 59 59 116 228
ALBUTEROL SULFATE 58 58 118 102
EXELON 58 58 118 164
NABUMETONE 56 41 120 201
FLUCONAZOLE 56 49 120 195
OXYCODONE-ACETAMINOPHEN 55 37 S2 122 59
GLIPIZIDE 55 51 122 47
LANTUS SOLOSTAR 55 54 122 90
NOVOLOG 52 50 125 94
TRIMETHOPRIM 51 51 126 297
INDAPAMIDE 51 51 126 199
HUMALOG MIX 75-25 50 23 128 237
IBUPROFEN 50 45 128 80
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 12, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.